[MDGL] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
31-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 44.84%
YoY- 26.45%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -27,740 -11,475 -8,445 -7,749 -10,536 -20,352 -24,162 2.32%
Tax -28 -25 -276 142 0 0 0 -
NP -27,740 -11,475 -8,445 -7,749 -10,536 -20,352 -24,162 2.32%
Tax Rate - - - - - - - -
Total Cost 27,740 11,475 8,445 7,749 10,536 20,352 24,162 2.32%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -1.80 -0.75 -0.67 -0.67 -2.68 -6.57 -9.90 -24.72%
EPS Diluted -1.80 -0.75 -0.67 -0.67 -2.68 -6.57 -9.90 -24.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.